Photo: Indranil Bhoumik/MintWashington: A new gene therapy has helped restore vision in people who had lost their sight to an inherited retinal disease, scientists say. This new, first-of-its-kind gene therapy is currently under review by the US Food and Drug Administration (FDA) for potential approval this year. In the future, gene therapy could possibly provide key proteins needed to restore vision in more common diseases such as age-related macular degeneration. More than 200 patients with LCA have participated in gene therapy trials since 2007. However, no gene therapy has gotten this close to FDA approval for retinal disease or any other eye disease.

Source: Mint November 11, 2017 10:30 UTC